NCM 109 Care of Mother, Child and Adolescent (Well patient)

RELATED LEARNING EXPERIENCE (RLE)

Date of Order: June 21, 2021

Generic Name: Erceflora Nursing Responsibilities

Action Rationale
Brand Name: Erceflora 1. Monitor patient for diarrhea. Drug may need to be stopped.
2. Tell patient to report adverse reaction May be signs of overdose.
promptly.

Classification: Probiotic 3. Inform patient that fever and These are the most common reactions to the
increased WBC count are normal. drug.
Dose/ Route/Frequency: 4. Use cautiously in patients allergic to other Because of possible cross-sensitivity.
1sachet/ TID/ PO drugs, especially to cephalosporins.

Mechanism of Action: Bacillus clausii (Erceflora) is a 5. Shake well before injecting. To make sure there is no residue of the drug.
preparation composed of a suspension of Bacillus
clausii spores. These spores are part of the normal intestinal
flora and have no pathogenic potential. Administered via the
oral route, Bacillus clausii spores overcome the gastric acid
barrier due to their high resistance to both chemical and
physical agents, and reach the intestinal tract intact where
they are transformed into metabolically active vegetative
cells.
Desired Effect: Treatment and prophylaxis of 6. If CDAD is suspected or confirmed, Drug may cause CDAD ranging in severity
intestinal dysmicrobism and subsequent endogenous drug may need to be discontinued from mild diarrhea to fatal colitis.
dysvitaminosis. Therapy for aiding the recovery of and treatment initiated.
the intestinal microbial flora, altered during the
course of treatment with antibiotics or
chemotherapeutic agents. Acute and chronic
gastrointestinal disorders in breastfed infants,
attributable to intoxication or intestinal
dysmicrobism and dysvitaminosis.
NCM 109 Care of Mother, Child and Adolescent (Well patient)
RELATED LEARNING EXPERIENCE (RLE)